Ben Roberts and David Price, who head up PRIUM's regulatory and compliance consulting team, have authored a great piece on medical marijuana rules and statutes across the country. The article is data-driven, well-researched, and should have a calming effect on payer organizations concerned about the potential need to reimburse for medical marijuana.
Did you know that of the 24 states with medical marijuana laws, most have either explicit or implicit provisions allowing for commercial payers to avoid reimbursement for medical marijuana?
Did you know that most of these states have a list of allowable conditions that provide a second layer of potential protection for commercial payers?
Did you know that most of these states have medical treatment guidelines that address the use of medical marijuana?
Did you know that the New Mexico cases that have most of our industry concerned about this issue exhibit systemic failure on the part of the payers in those cases to take advantage of these various provisions and protections?
We're not suggesting that medical marijuana is a non-event that deserves no attention. We're suggesting that smart payers with smart medical management strategies need not fear being overwhelmed with medical marijuana spend.
Check out the full article here.
On Twitter @PRIUM1